From Innovation to Commercial Excellence: Tailored Manufacturing of Peptides and Beta-Lactam APIs in Europe.

In the rapidly evolving European pharmaceutical landscape, sustainability, environmental impact reduction, and supply chain resilience are driving the continuous improvement of manufacturing processes through innovation. At the same time, European initiatives to reshore active pharmaceutical ingredient (API) production are opening new opportunities for strategic manufacturing capabilities within Europe. Within these contexts, this presentation will discuss the innovative solutions available in Fresenius Kabi iPSUM for the peptide API manufacturing and characterization, a class of molecules that gained significant market relevance following the exponential growth of GLP-1 analogues.

The presentation will also highlight established, tailored manufacturing solutions for beta-lactam antibiotic APIs, which have become increasingly relevant in the context of the Critical Medicines Act.